Clik here to view.
Here are the pharma companies accused of blocking generic competition
To prove a generic drug is as safe and effective as the branded version, pharmaceutical companies have to hand over upwards of 1,000 doses of the product to a generic developer. But if the manufacturer...
View ArticleClik here to view.
West Pharmaceutical boosts its analytical services with new technology
West Pharmaceutical Services (NYSE:WST) has expanded its analytical services capabilities with new equipment to help address the pharmaceutical industry’s packaging and drug-delivery concerns, the...
View ArticleClik here to view.
With groundbreaking approval, Amgen launches new class of medicine for...
Amgen (NSDQ:AMGN) won FDA approval this week for its once-monthly Aimovig injection designed to prevent the onset of migraines in adults. The drug is the first of its kind – a molecule that blocks the...
View ArticleClik here to view.
Valeritas touts new data for insulin delivery device
Valeritas (NSDQ:VLRX) touted data today from two new studies of its V-Go wearable insulin delivery device in patients with Type II diabetes. In one three-month evaluation of 60 people with Type II...
View ArticleClik here to view.
Here’s how Sanofi separates true innovation from all the hype in digital health
Recognizing that digital technology is here to stay in the business of healthcare, pharmaceutical companies have not shied away from collaborating with the folks in Silicon Valley. Sanofi (NYSE:SNY),...
View ArticleClik here to view.
GlaxoSmithKline touts long-term study of biologic treatment for severe...
GlaxoSmithKline (NYSE:GSK) touted new data today from a long-term study of its biologic treatment for patients with severe eosinophilic asthma. One-third of patients treated with mepolizumab...
View ArticleClik here to view.
Valeritas inks distro deal for V-Go device in Austria, Germany
Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Med Trust to commercialize its V-Go insulin delivery device in Austria and Germany. According to the terms of the...
View ArticleClik here to view.
GSK’s Arnuity Ellipta asthma therapy wins FDA nod for use in kids as young as...
GlaxoSmithKline (NYSE:GSK) won FDA approval for the use of its Arnuity Ellipta inhaler as a once-daily therapy for the maintenance treatment of asthma in children as young as five years old. The...
View ArticleClik here to view.
MIT researchers devise single-injection delivery method for polio vaccine
Photo courtesy of MIT Although most of the world is protected from the polio virus thanks to a vaccine developed decades ago, some countries remain vulnerable to the disease thanks to challenges posed...
View ArticleClik here to view.
Tribe taking steps to ‘ramp up’ drug patent business
The Native American tribe wrapped up in litigation with generic pharmaceutical companies is trying to prove that its arrangement with Allergan (NYSE:AGN) reflects a legitimate move to boost its...
View ArticleClik here to view.
RenovoRx raises $7m for drug-device pancreatic cancer therapy
RenovoRx said today that it closed a $7 million tranche in a $10 million round to fund the development of its drug-device combination product designed to deliver chemotherapy directly to tumors in...
View ArticleClik here to view.
Beta Bionics wins FDA nod for home-use trial of artificial pancreas tech
Beta Bionics said this week that it won FDA approval to start recruiting patients with Type I diabetes for home-use studies of its iLet bionic pancreas system. The trial is slated to test Novo...
View ArticleClik here to view.
EuroPCR 2018: Study compares drug-coated balloons in patients with arterial...
At this year’s annual EuroPCR meeting, Boston Scientific (NYSE:BSXtouted results from the first trial to compare two drug-coated balloons with different drug formulations – Boston Scientific’s Agent...
View ArticleClik here to view.
FDA approves Abbott’s latest drug-eluting stent
Abbott (NYSE:ABT) said today that it won FDA approval for its Xience Sierra everolimus-eluting coronary stent. The company’s device features a thin profile, improved flexibility and longer lengths than...
View ArticleClik here to view.
EuroPCR Roundup: Biotronik touts two-year study comparing drug-eluting stents
Biotronik yesterday presented two-year data from a trial comparing Boston Scientific‘s (NYSE:BSX) Synergy biodegradable polymer everolimus-eluting stent, Biotronik’s Orsiro sirolimus-eluting stent and...
View ArticleClik here to view.
Reva Medical’s Fantom bioresorbable scaffold succeeds in two-year trial
Reva Medical (ASX:RVA) touted sustained safety and efficacy results for its Fantom bioresorbable scaffold at this year’s EuroPCR meeting. The company also revealed new information about its suite of...
View ArticleClik here to view.
MIT researchers send drug-ferrying nanoparticles across the blood-brain barrier
Image courtesy of MIT Researchers at the Massachusetts Institute of Technology demonstrated in an animal study that nanoparticles shuttling two different cancer drugs could effectively cross the...
View ArticleClik here to view.
Report: Trump to sign controversial law granting patients access to...
President Donald Trump is slated to approve legislation this week that will give terminally-ill patients access to experimental drugs that haven’t yet been cleared by the FDA. The “right-to-try” bill...
View ArticleClik here to view.
NanOlogy touts preclinical data for inhaled NanoPac cancer drug
NanOlogy touted results today from preclinical studies of its inhaled submicron particle formulation of paclitaxel, NanoPac. The company said animal studies have shown prolonged retention of the cancer...
View ArticleClik here to view.
Sage Therapeutics wins priority review for intravenous postpartum depression...
Sage Therapeutics (NSDQ:SAGE) said today that the FDA accepted its new drug application for an intravenous formulation of brexanolone as a treatment for postpartum depression. The application was...
View Article